Navigation Links
Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation

MURRYSVILLE, Pa., Nov. 6 /PRNewswire/ -- Philips Respironics applauds the efforts of the Centers for Disease Control and Prevention (CDC) to raise awareness about an important public health issue -- chronic sleep insufficiency. The CDC's release of the first-ever government study to monitor state-by-state differences in sleeplessness is a milestone in quantifying the size and scope of the problem.

As a long-time educator, industry leader and sleep therapy manufacturer, Philips Respironics supports government efforts to draw attention to chronic sleep insufficiency, which remains under-reported and under-treated despite being associated with numerous physical and mental health problems, injury and mortality. It is estimated that 50 to 70 million Americans chronically suffer from a disorder of sleep and wakefulness, hindering daily functioning and adversely affecting their health and longevity.

Sleep - along with diet and exercise - is the third leg of the stool of good health. Nothing would have greater impact in reducing the health and safety toll of chronic sleep deprivation than the CDC's recommendation that healthcare providers consider adding an assessment of chronic rest or sleep insufficiency to routine office visits

Philips Respironics is dedicated to helping diagnose and improve the quality of life for Americans who experience sleep disorders. In 1985 we were the first company to commercialize continuous positive airway pressure (CPAP) therapy for treating Obstructive Sleep Apnea (OSA), a condition where a person's airway collapses repeatedly during sleep, preventing proper respiration and adequate rest. Today, CPAP therapy is the first-line of treatment for millions of OSA sufferers.

Sleep apnea is one of the world's most common sleep disorders, linked to a host of health problems including hypertension, insulin resistance, and increased risk of heart attack, stroke, and heart failure. We look forward to working with the government to educate Americans about sleep, sleep disorders, and the consequences of sleep deprivation.

SOURCE Philips Healthcare

SOURCE Philips Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
2. PhRMA Statement Supporting Fair Incentives for Biologics Innovation
3. PhRMA Statement on Senate Finance Committee Vote
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
6. EAU Position Statement on Screening for Prostate Cancer
7. Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients
8. A Joint Statement From Americas Prostate Cancer Advocacy, Education, and Support Organizations
9. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
10. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
11. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):